Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Boeri

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Patient Preference and Adherence|July 3, 2020
Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in ColombiaPeita L Graham-Clarke, Brett Hauber, Marco Boeri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Caution is needed for systematic reviews and interpretation of preference studiesJennifer A Whitty, Brett Hauber, Josh Coulter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2021
Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male YouthElizabeth T Montgomery, Erica N Browne, Millicent Atujuna, et al.
European Journal of Pain (London, England)|December 2, 2021
Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysisDavid A Walsh, Marco Boeri, Lucy Abraham, et al.
The Journal of Dermatological Treatment|January 15, 2024
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experimentSteven R Feldman, Jacob P Thyssen, Marco Boeri, et al.
Journal of the International AIDS Society|June 17, 2020
Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experimentAlexandra M Minnis, Millicent Atujuna, Erica N Browne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2022
Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group ReportCaroline Vass, Marco Boeri, Suzanna Karim, et al.
The Journal of Dermatological Treatment|October 27, 2024
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and GermanyNicholas Durno, Pablo Arija, Krystallia Pantiri, et al.
Journal of Patient-Reported Outcomes|April 14, 2026
Burden and disutility of sleep disturbance and early morning OFF symptoms in people with advancing Parkinson's disease: a vignette-based approach using the EQ-5D-5LJosefa Domingos, Pablo Arija, Irene A Malaty, et al.
AIDS and Behavior|November 8, 2019
Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice ExperimentErica N Browne, Elizabeth T Montgomery, Carol Mansfield, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Patient Preference and Adherence|July 3, 2020
Patient Preferences for Biologic and Biosimilar Osteoporosis Treatments in ColombiaPeita L Graham-Clarke, Brett Hauber, Marco Boeri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 11, 2026
Caution is needed for systematic reviews and interpretation of preference studiesJennifer A Whitty, Brett Hauber, Josh Coulter, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2021
Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male YouthElizabeth T Montgomery, Erica N Browne, Millicent Atujuna, et al.
European Journal of Pain (London, England)|December 2, 2021
Exploring patient preference heterogeneity for pharmacological treatments for chronic pain: A latent class analysisDavid A Walsh, Marco Boeri, Lucy Abraham, et al.
The Journal of Dermatological Treatment|January 15, 2024
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experimentSteven R Feldman, Jacob P Thyssen, Marco Boeri, et al.
Journal of the International AIDS Society|June 17, 2020
Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experimentAlexandra M Minnis, Millicent Atujuna, Erica N Browne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2022
Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group ReportCaroline Vass, Marco Boeri, Suzanna Karim, et al.
The Journal of Dermatological Treatment|October 27, 2024
Biologics and oral systemic treatment preferences in patients and physicians for moderate-to-severe atopic dermatitis: a discrete choice experiment in the United Kingdom and GermanyNicholas Durno, Pablo Arija, Krystallia Pantiri, et al.
Journal of Patient-Reported Outcomes|April 14, 2026
Burden and disutility of sleep disturbance and early morning OFF symptoms in people with advancing Parkinson's disease: a vignette-based approach using the EQ-5D-5LJosefa Domingos, Pablo Arija, Irene A Malaty, et al.
AIDS and Behavior|November 8, 2019
Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice ExperimentErica N Browne, Elizabeth T Montgomery, Carol Mansfield, et al.
Pageof 6